Forbes: MDMA Press Release

New research from the University of Cincinnati suggests that MDMA can increase the survival of dopamine cells in the brain during fetal development, which are critical in the regulation of voluntary movement, potentially leading to better therapies for neurological diseases like Parkinson’s. The press release mentioned MAPS-sponsored research evaluating MDMA-assisted therapy as a treatment for posttraumatic stress disorder (PTSD). Forbes Magazine also reported on this research, along with a report on new research from Ohio State University validating other findings that the active ingredients in marijuana may slow the progression of Alzheimer’s disease.